Cargando…
Foamy Virus Vectors for HIV Gene Therapy
Highly active antiretroviral therapy (HAART) has vastly improved outcomes for patients infected with HIV, yet it is a lifelong regimen that is expensive and has significant side effects. Retroviral gene therapy is a promising alternative treatment for HIV/AIDS; however, inefficient gene delivery to...
Autores principales: | Olszko, Miles E., Trobridge, Grant D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814606/ https://www.ncbi.nlm.nih.gov/pubmed/24153061 http://dx.doi.org/10.3390/v5102585 |
Ejemplares similares
-
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
por: Nalla, Arun K., et al.
Publicado: (2016) -
Large Animal Models for Foamy Virus Vector Gene Therapy
por: Trobridge, Grant D., et al.
Publicado: (2012) -
A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
por: Everson, Elizabeth M, et al.
Publicado: (2016) -
In-Vivo Gene Therapy with Foamy Virus Vectors
por: Rajawat, Yogendra Singh, et al.
Publicado: (2019) -
Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes
por: Hocum, Jonah D., et al.
Publicado: (2016)